Vanguard Group’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.1M | Buy |
4,524,952
+217,761
| +5% | +$2.03M | ﹤0.01% | 2213 |
|
|
2025
Q1 | $29M | Buy |
4,307,191
+1,303,753
| +43% | +$8.77M | ﹤0.01% | 2335 |
|
|
2024
Q4 | $31.9M | Sell |
3,003,438
-128,130
| -4% | -$1.36M | ﹤0.01% | 2357 |
|
|
2024
Q3 | $45.8M | Buy |
3,131,568
+210,356
| +7% | +$3.08M | ﹤0.01% | 2220 |
|
|
2024
Q2 | $35.3M | Buy |
2,921,212
+901,474
| +45% | +$10.9M | ﹤0.01% | 2287 |
|
|
2024
Q1 | $49.8M | Buy |
2,019,738
+279,712
| +16% | +$6.9M | ﹤0.01% | 2167 |
|
|
2023
Q4 | $18.6M | Buy |
1,740,026
+1,343,697
| +339% | +$14.4M | ﹤0.01% | 2628 |
|
|
2023
Q3 | $3.31M | Buy |
396,329
+22,451
| +6% | +$187K | ﹤0.01% | 3416 |
|
|
2023
Q2 | $2.96M | Hold |
373,878
| – | – | ﹤0.01% | 3529 |
|
|
2023
Q1 | $1.87M | Hold |
373,878
| – | – | ﹤0.01% | 3701 |
|
|
2022
Q4 | $826K | Buy |
373,878
+193
| +0.1% | +$427 | ﹤0.01% | 3973 |
|
|
2022
Q3 | $1.66M | Buy |
373,685
+3,149
| +0.8% | +$14K | ﹤0.01% | 3819 |
|
|
2022
Q2 | $1.19M | Hold |
370,536
| – | – | ﹤0.01% | 4021 |
|
|
2022
Q1 | $2.11M | Sell |
370,536
-5,822
| -2% | -$33.1K | ﹤0.01% | 3937 |
|
|
2021
Q4 | $4.88M | Buy |
376,358
+3,878
| +1% | +$50.3K | ﹤0.01% | 3623 |
|
|
2021
Q3 | $9.07M | Buy |
372,480
+70,388
| +23% | +$1.71M | ﹤0.01% | 3297 |
|
|
2021
Q2 | $5.23M | Buy |
302,092
+147,863
| +96% | +$2.56M | ﹤0.01% | 3577 |
|
|
2021
Q1 | $5.23M | Buy |
+154,229
| New | +$5.23M | ﹤0.01% | 3510 |
|